Private Trust Co. NA Trims Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Private Trust Co. NA lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,648 shares of the exchange traded fund’s stock after selling 268 shares during the period. Private Trust Co. NA’s holdings in SPDR S&P Biotech ETF were worth $238,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC raised its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $85.60 on Tuesday. The company has a 50 day moving average price of $90.88 and a two-hundred day moving average price of $95.66. The stock has a market capitalization of $5.65 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.